1996
DOI: 10.1093/clinids/22.1.1
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Spectrum of Leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

8
312
0
24

Year Published

1998
1998
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 466 publications
(344 citation statements)
references
References 41 publications
8
312
0
24
Order By: Relevance
“…Clinical symptoms result from replication of the parasites in macrophages of the dermis, naso-oropharyngeal mucosa, and the mononuclear phagocyte system, respectively (reviewed in Refs. [1][2][3]. Leishmaniasis is prevalent in four continents and is considered by the World Health Organization to be one of the top six most important human parasitic diseases.…”
Section: Identification and Characterization Of T Cell-stimulating Anmentioning
confidence: 99%
See 1 more Smart Citation
“…Clinical symptoms result from replication of the parasites in macrophages of the dermis, naso-oropharyngeal mucosa, and the mononuclear phagocyte system, respectively (reviewed in Refs. [1][2][3]. Leishmaniasis is prevalent in four continents and is considered by the World Health Organization to be one of the top six most important human parasitic diseases.…”
Section: Identification and Characterization Of T Cell-stimulating Anmentioning
confidence: 99%
“…In 1990, estimates by the World Health Organization indicated that ϳ350 million people were at risk of acquiring leishmaniasis and that 12 million were currently infected (4). In a recent epidemic of visceral leishmaniasis (VL) 3 in southern Sudan, Medicins San Frontièrers estimated that the excess mortality has been about 100,000 deaths among about 300,000 people at risk (5).…”
Section: Identification and Characterization Of T Cell-stimulating Anmentioning
confidence: 99%
“…The clinical forms of leishmaniasis depend on the association among the virulent characteristics of the infective Leishmania and host susceptibility to the illnesses (Pearson and Souza, 1996). Leishmaniasis is categorized as cutaneous, mucocutaneous, diffuse cutaneous, and visceral.…”
Section: Introductionmentioning
confidence: 99%
“…1 Apresentando-se com febre, perda de peso gradual, esplenomegalia, hipergamaglobulinemia e pancitopenia, esta doença é fatal se não diagnosticada e tratada. 2 Portanto, um método simples de diagnóstico é essencial. De mesma importância é a validade do diagnóstico, uma vez que, a terapia anti-leishmania frequentemente resulta em significante mortalidade e morbidade.…”
Section: Introductionunclassified